Are Elevated Vancomycin Serum Trough Concentrations Achieved Within the First 7 Days of Therapy Associated With Acute Kidney Injury in Children?
about
The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit.Pharmacodynamic Characteristics of Nephrotoxicity Associated With Vancomycin Use in Children.Healthcare-associated Staphylococcus aureus Bacteremia in Children: Evidence for Reverse Vancomycin Creep and Impact of Vancomycin Trough Values on OutcomeFactors associated with acute kidney injury in children receiving vancomycin.Optimizing Guideline-Recommended Antibiotic Doses for Pediatric Infective Endocarditis.Balancing vancomycin efficacy and nephrotoxicity: should we be aiming for trough or AUC/MIC?Frequency of and Risk Factors for Acute Kidney Injury Associated With Vancomycin Use in the Pediatric Intensive Care Unit.Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.Association of Vancomycin Trough Concentration With Response to Treatment for Acute Pulmonary Exacerbation of Cystic Fibrosis.Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin.Retrospective analysis of vancomycin treatment outcomes in Chinese paediatric patients with suspected Gram-positive infection.Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study.Increased Vancomycin Exposure and Nephrotoxicity in Children: Therapeutic Does Not Mean SafePiperacillin-tazobactam versus cefepime incidence of acute kidney injury in combination with vancomycin and tobramycin in pediatric cystic fibrosis patients.Adverse effects of intravenous vancomycin-based prophylaxis during therapy for pediatric acute myeloid leukemia.Vancomycin Versus Vancomycin Plus Rifampin for the Treatment of Acute Pulmonary Exacerbations of Cystic Fibrosis.
P2860
Q36277424-E441DC8B-ED05-4A0F-8D57-D950E6118D80Q36377410-3741D2D1-DDCF-4023-AD6B-07E1E28F7C11Q36576652-712EEA90-A01A-4E39-BE3F-043DD23096C2Q38245931-DE3C44CF-A2B6-4392-A82D-AA9689EE43DFQ38903089-3E12057F-9834-45B7-BA83-16D4EFA4BDD8Q39044128-47426EC7-3C26-4A89-ACFA-FB435CDB0990Q39054927-37218B24-7782-4461-AE74-75F09DDB3122Q39340850-F4F0153D-58B5-4FA2-A09E-F08B69E38CAFQ40048536-3722C99C-89E3-40F4-A115-B162294EFFBDQ40441139-1407F8AF-C515-4515-8B82-E88774858442Q40483780-B6D6BB5E-E531-4993-8297-0AED33915475Q41115090-8F0C20BC-22D8-43BB-81EE-78062445C738Q41158049-5700818C-0429-43C0-82DF-F250995D805CQ41255520-8F93187C-B3C8-4ECE-B608-9D7CA9667C9DQ42580002-998920FC-C139-4BEA-B448-7206E0E4AB63Q48234771-FBB49161-D764-41C2-AEBA-8A2FA3B444A5Q49921680-1B24C38B-FD31-4BA9-A1E5-341AD0EAA00AQ53688751-A6C82940-0294-4943-99E6-C60D84B72265
P2860
Are Elevated Vancomycin Serum Trough Concentrations Achieved Within the First 7 Days of Therapy Associated With Acute Kidney Injury in Children?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Are Elevated Vancomycin Serum ...... ute Kidney Injury in Children?
@en
type
label
Are Elevated Vancomycin Serum ...... ute Kidney Injury in Children?
@en
prefLabel
Are Elevated Vancomycin Serum ...... ute Kidney Injury in Children?
@en
P2093
P2860
P356
P1476
Are Elevated Vancomycin Serum ...... ute Kidney Injury in Children?
@en
P2093
Amy C Wilson
Chad A Knoderer
Kelsey C Lyon
Kristen R Nichols
Megan M Veverka
P2860
P304
P356
10.1093/JPIDS/PIT076
P577
2013-11-11T00:00:00Z